Eli Lilly and Company has received its third U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab).
from The Medical News http://ift.tt/1BUFa6Z
from The Medical News http://ift.tt/1BUFa6Z
Our mission is to advice, and to make the people of the world healthier through the power of information.
No comments:
Post a Comment